Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Abolishes Confirmation Application System for Regenerative Medicines
July 11, 2011
- MRs should Help Improve Quality of Healthcare as Medical Team Members: Prof. Muto
July 11, 2011
- Astellas Sells DPP-4 Inhibitor-related Patent Estate to Royalty Pharma for US$609 Mil.
July 11, 2011
- FDA Accepts Pfizer's Application for Axitinib for RCC
July 11, 2011
- Celecoxib Significantly Lowers Incidence of Ulcers vs Loxoprofen
July 11, 2011
- CMIC to Acquire Investigational Drug Manufacturing Facilities from Daiichi Sankyo
July 11, 2011
- Regenerative Medicine Industry Organization Kicks Off
July 11, 2011
- JES Calls for Approval of Monotherapy with Novel Antiepileptic Agents
July 11, 2011
- Sogo Medical to Increase Number of Mentaio Pharmacies to 20 in 3 Years
July 11, 2011
- DPJ Lawmakers Call for Withdrawal of Proposal to Unify Basic Dispensing Fees
July 11, 2011
- DPJ's Diet Members Adopt Opinion Paper Calling for Deregulating Online Sales of OTC Drugs
July 11, 2011
- Mediceo to Use Its MR-Certified MSs to Promote Orphan Drugs
July 11, 2011
- Ono, Evotec Succeed in Discovering Lead Compounds in Iron Channel Drug Discovery
July 11, 2011
- Eisai to Enhance Liver Disease Franchise in Asia/Pacific Region
July 11, 2011
- Sprycel Approved as 1st-line Treatment for CML: Bristol-Myers, Otsuka
July 4, 2011
- Wakamoto Licenses Ophthalmic Surgical Adjuvant from Kyushu Univ. Bioventure
July 4, 2011
- PMDA to Give Priority to Regenerative Medicine, Cancer in Regulatory Strategy Consultation
July 4, 2011
- Number of Deaths Reached Post-war High in 2010: Korosho
July 4, 2011
- Astellas Transfers Luvox to Abbott Japan
July 4, 2011
- Korosho Asks Takeda to Revise Package Insert for Actos
July 4, 2011
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…